<DOC>
	<DOCNO>NCT00473525</DOCNO>
	<brief_summary>The purpose Phase 2a study evaluate efficacy , safety tolerability , multiple parallel dos PF-00734200 follow oral administration adult human subject T2DM currently stable dose metformin .</brief_summary>
	<brief_title>12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diagnosis type 2 diabetes Hb1AC &gt; 7 % 11 % inclusive Male female 1870 ; female must postmenopausal On stable dose metformin hydrochloride Medical history stroke , unstable angina , heart attack within one year enrollment , alcohol dependency recent drug abuse . Women childbearing potential , pregnant nursing Evidence diabetic complication significant endorgan damage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>